(Nasdaq: ADMA) ("ADMA" or the "Company"), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced its ...

Early detection and prompt treatment of acute pulmonary embolism (PE), a sudden and potentially life-threatening blood clot that blocks arteries in the lungs, is critical. Comprehensive ...

Air pollution cannot be eliminated by individual effort alone, but exposure can be reduced and lung injury can be slowed.

A woman in her late 20s presented with a 5-year history of progressive fatigue and generalised weakness. Examination revealed signs of premature ageing, anaemia, neuropathy and hepatosplenomegaly.

Venous disease once considered a problem of older adults is emerging as a health concern for young professionals due to ...

A causal link is plausible, researchers say ...

The first clinical practice guideline on acute pulmonary embolism (PE) from the American Heart Association and the American ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...

A team led by Northwestern University and Shirley Ryan AbilityLab scientists have developed a new technology that can ...

Use of race-based reference equations in pulmonary function testing has led to thresholds for what qualifies as impairment in populations.

Full-body MRIs are all the rage. We take a look at three major companies offering such testing.